• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail

FDA Approval of Generic Ribavirin for Treatment of Chronic Hepatitis C

On April 6, 2004, FDA approved two generic versions of the drug, ribavirin, Ribavirin Capsules, 200 mg, made by Geneva Pharmaceuticals, and Ribasphere Capsules, 200 mg, made by Three Rivers Pharmaceuticals, L.L.C., for the treatment of Chronic Hepatitis C.

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration